Literature DB >> 22377967

Risk of ventricular arrhythmias after myocardial infarction with diabetes associated with sympathetic neural remodeling in rabbits.

Ye Wang1, Yong-Li Xuan, He-Sheng Hu, Xiao-Lu Li, Mei Xue, Wen-Juan Cheng, Fei Suo, Su-Hua Yan.   

Abstract

BACKGROUND: Abnormal sympathetic innervation underlies both long-term hyperglycemia and myocardial infarction (MI). The incidence of ventricular arrhythmias (VAs) after MI is higher in diabetic than in nondiabetic patients. However, the exact mechanism remains unclear. In this study, we aimed to explore sympathetic neural remodeling after MI in diabetic rabbits and its relationship with VAs.
METHODS: Rabbits were randomly assigned to 4 groups: control, diabetes mellitus (DM), MI and diabetic myocardial infarction (DI). After electrophysiological experiments in vivo, immunohistochemistry and real-time RT-PCR were used to measure sympathetic innervations. To test the function of sympathetic nerve fibers, norepinephrine levels were measured by high-performance liquid chromatography.
RESULTS: The corrected QT interval and QT dispersion were significantly more prolonged with DI than other conditions. The density of tyrosine hydroxylase-positive fibers and corresponding mRNA abundance was significantly higher with DI than with DM and under control conditions, but was lower than with the MI group. Moreover, the distribution and structure of regenerated nerve was heterogeneous in DI rabbits. Norepinephrine content was higher in the DI group, and accompanied by an increased quantity of tyrosine hydroxylase-positive fibers.
CONCLUSION: MI results in sympathetic neural remodeling in diabetic rabbits, which may be responsible in part for the increased occurrence of VAs.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22377967     DOI: 10.1159/000336148

Source DB:  PubMed          Journal:  Cardiology        ISSN: 0008-6312            Impact factor:   1.869


  8 in total

Review 1.  Modeling and imaging cardiac sympathetic neurodegeneration in Parkinson's disease.

Authors:  Valerie Joers; Marina E Emborg
Journal:  Am J Nucl Med Mol Imaging       Date:  2014-03-20

Review 2.  Implantable cardioverter defibrillators in diabetics: efficacy and safety in patients at risk of sudden cardiac death.

Authors:  Muhammad Shahreyar; Vijayadershan Mupiddi; Indrajit Choudhuri; Jasbir Sra; Abdul Jamil Tajik; Arshad Jahangir
Journal:  Expert Rev Cardiovasc Ther       Date:  2015-06-22

3.  High mobility group box-1 in hypothalamic paraventricular nuclei attenuates sympathetic tone in rats at post-myocardial infarction.

Authors:  Pang Li; Yin Jie; Shi YuGen; Wang Yu; Suhua Yan
Journal:  Cardiol J       Date:  2018-10-19       Impact factor: 2.737

4.  Spironolactone Regulates HCN Protein Expression Through Micro-RNA-1 in Rats With Myocardial Infarction.

Authors:  Hua-Dong Yu; Shuang Xia; Cheng-Qin Zha; Song-Bai Deng; Jian-Lin Du; Qiang She
Journal:  J Cardiovasc Pharmacol       Date:  2015-06       Impact factor: 3.105

Review 5.  Autonomic cardiac innervation: development and adult plasticity.

Authors:  Wohaib Hasan
Journal:  Organogenesis       Date:  2013-05-14       Impact factor: 2.500

6.  Autonomic remodeling may be responsible for decreased incidence of aortic dissection in STZ-induced diabetic rats via down-regulation of matrix metalloprotease 2.

Authors:  Rui Hu; Zhiwei Wang; Zongli Ren; Min Liu
Journal:  BMC Cardiovasc Disord       Date:  2016-10-21       Impact factor: 2.298

7.  Over-expression of microRNA-145 drives alterations in β-adrenergic signaling and attenuates cardiac remodeling in heart failure post myocardial infarction.

Authors:  Zhebo Liu; Bo Tao; Suzhen Fan; Shengyu Cui; Yong Pu; Liqiang Qiu; Hao Xia; Lin Xu
Journal:  Aging (Albany NY)       Date:  2020-06-18       Impact factor: 5.682

8.  MicroRNA-145 Protects against Myocardial Ischemia Reperfusion Injury via CaMKII-Mediated Antiapoptotic and Anti-Inflammatory Pathways.

Authors:  Zhebo Liu; Bo Tao; Suzhen Fan; Yong Pu; Hao Xia; Lin Xu
Journal:  Oxid Med Cell Longev       Date:  2019-09-10       Impact factor: 6.543

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.